Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the writing committee of the American society for apheresis: the …
J Schwartz, A Padmanabhan, N Aqui… - Journal of clinical …, 2016 - Wiley Online Library
The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special
Issue Writing Committee is charged with reviewing, updating, and categorizing indications …
Issue Writing Committee is charged with reviewing, updating, and categorizing indications …
A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury
Hematopoietic stem cell transplantation (HSCT)-associated thrombotic microangiopathy (TA-
TMA) is now a well-recognized and potentially severe complication of HSCT that carries a …
TMA) is now a well-recognized and potentially severe complication of HSCT that carries a …
Guidelines on the use of therapeutic apheresis in clinical practice—evidence‐based approach from the Writing Committee of the American Society for Apheresis: the …
The American Society for Apheresis (ASFA) JCA Special Issue Writing Committee is
charged with reviewing, updating and categorizating indications for therapeutic apheresis …
charged with reviewing, updating and categorizating indications for therapeutic apheresis …
Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults
Transplant-associated thrombotic microangiopathy (TMA) leads to generalized endothelial
dysfunction that can progress to multiorgan injury, and severe cases are associated with …
dysfunction that can progress to multiorgan injury, and severe cases are associated with …
Transplant-associated thrombotic microangiopathy: theoretical considerations and a practical approach to an unrefined diagnosis
JA Young, CR Pallas, MA Knovich - Bone Marrow Transplantation, 2021 - nature.com
Transplant-associated thrombotic microangiopathy (TA-TMA) is an increasingly recognized
complication of hematopoietic stem cell transplant (HSCT) with high morbidity and mortality …
complication of hematopoietic stem cell transplant (HSCT) with high morbidity and mortality …
Guidelines on the use of therapeutic apheresis in clinical practice—evidence‐based approach from the Apheresis Applications Committee of the American Society for …
ZM Szczepiorkowski, JL Winters… - Journal of clinical …, 2010 - Wiley Online Library
Abstract The American Society for Apheresis (ASFA) Apheresis Applications Committee is
charged with a review and categorization of indications for therapeutic apheresis. Beginning …
charged with a review and categorization of indications for therapeutic apheresis. Beginning …
Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation–associated thrombotic microangiopathy
Transplantation-associated thrombotic microangiopathy (TA-TMA) is a challenging
diagnosis after hematopoietic stem cell transplantation. Although endothelial injury …
diagnosis after hematopoietic stem cell transplantation. Although endothelial injury …
[HTML][HTML] Eculizumab therapy in children with severe hematopoietic stem cell transplantation–associated thrombotic microangiopathy
S Jodele, T Fukuda, A Vinks, K Mizuno… - Biology of Blood and …, 2014 - Elsevier
We recently observed that dysregulation of the complement system may be involved in the
pathogenesis of hematopoietic stem cell transplantation–associated thrombotic …
pathogenesis of hematopoietic stem cell transplantation–associated thrombotic …
Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation
BS Cho, SA Yahng, SE Lee, KS Eom, YJ Kim… - …, 2010 - journals.lww.com
Background. The lack of an accepted definition of transplantation-associated thrombotic
microangiopathy (TMA) has led the Blood and Marrow Transplants Clinical Trials Network …
microangiopathy (TMA) has led the Blood and Marrow Transplants Clinical Trials Network …
COVID‐19‐induced endotheliitis: emerging evidence and possible therapeutic strategies
E Calabretta, JM Moraleda, M Iacobelli… - British Journal of …, 2021 - Wiley Online Library
The coronavirus disease 2019 (COVID-19) pandemic, a viral illness caused by the severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2), 1 has produced at the time of this …
acute respiratory syndrome coronavirus-2 (SARS-CoV-2), 1 has produced at the time of this …